Prosecution Insights
Last updated: September 17, 2026
Application No. 16/648,849

NOVEL COMPOSITION

Final Rejection §103
Filed
Mar 19, 2020
Priority
Sep 22, 2017 — GB 1715400.6 +1 more
Examiner
ROBERTS, LEZAH
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Glaxosmithkline Consumer Healthcare (Uk) Ip Limited
OA Round
9 (Final)
48%
Grant Probability
Moderate
10-11
OA Rounds
0m
Est. Remaining
84%
With Interview

Examiner Intelligence

Grants 48% of resolved cases
48%
Career Allowance Rate
372 granted / 770 resolved
-11.7% vs TC avg
Strong +35% interview lift
Without
With
+35.4%
Interview Lift
resolved cases with interview
Typical timeline
4y 1m
Avg Prosecution
48 currently pending
Career history
843
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
52.7%
+12.7% vs TC avg
§102
14.7%
-25.3% vs TC avg
§112
17.0%
-23.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 770 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicants' arguments in the Request for Continued Examination, filed January 16, 2026, have been fully considered. Rejections and/or objections not reiterated from previous office actions are hereby withdrawn. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims Claim Rejections - 35 USC § 103 – Obviousness (Maintained Rejection) Claims 1-4 and 6-8 are rejected under 35 U.S.C. 103 as being unpatentable over Xu et al. (US 2002/0031481) in view of Amano et al. (JP 2009137908). Xu et al. disclose dentifrice gel or paste compositions comprising about 40% to 70% by weight baking soda (sodium bicarbonate), natural or herbal ingredients, flavoring oils, xanthan gum, at least of betaine surfactant and a humectant (Abstract). The compositions also comprise water (Examples). Dentifrices have long been known and used to clean teeth and to combat plaque (paragraph 0003). Betaines include cocoamidopropyl betaine and cocoamidosulfobetaine and comprise 0.5 to 5% by weight of the composition (paragraph 0014). Sodium lauryl sulfate maybe used and comprises less than 2%. Natural or herbal ingredients include aloe (an anti-inflammatory agent, meeting instant claim 8). Sweeteners include stevioside (stevia) and comprise less than about 1% of the dentifrice formulations (paragraph 0033). A compositions comprises 67.262% baking soda, 0.85% xanthan gum, 4% cocoamidopropyl betaine (30%), glycerin, peppermint oil, sage oil and water (TABLE 1, Formula A). Xu et al. differ from the instant claims insofar as they do not disclose that sodium lauryl sulfate is used in combination with a betaine surfactant. Amano et al. disclose a dentifrice composition comprising a combination of a betaine surfactant and sodium lauryl sulfate. The weight ratio of sodium lauryl sulfate / betaine ranges from 0.3 to 300 (Abstract). The dentifrice composition of the present invention has an excellent gingival tightening feeling derived from sodium chloride, is excellent in foamability and foam persistence, and has a good feeling of use without bitterness. It was shown that a dentifrice composition containing sodium chloride, (B) xanthan gum, (C) a betaine-type amphoteric surfactant, and (D) sodium lauryl sulfate and blending so that (D) / (C) is 0.3 to 300 by mass ratio, excellent gingival tightening feeling and foaming during use was exhibited, and excellent foam sustainability and good bitterness without feeling bitterness was obtained. It was found that the salty taste of sodium bicarbonate or sodium chloride is alleviated. Betaines include cocamidopropyl betaine. It would have been obvious to one of ordinary skill in the art prior to filing the instant application to have used a combination of sodium lauryl sulfate and cocoamidopropyl betaine in a ratio ranging from 0.3 to 300 in the composition of Xu et al. motivated by the desire to use a combination that helps alleviate the salty taste of sodium bicarbonate. The prior art disclose a ratio of 0.3 to 300 whereas the instant claims recite 3:1 to 3.8:1 sodium lauryl sulfate to betaine. It is well-settled, however, that even a slight overlap in range establishes a prima facie case of obviousness. Accordingly, since an overlap plainly exists here, it would have been obvious to have selected values within the overlap. See MPEP 2144.05. Conclusion Claims 1-4 and 6-8 are rejected. No claims allowed. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to LEZAH ROBERTS whose telephone number is (571)272-1071. The examiner can normally be reached Monday-Friday 11:00-7:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sahana Kaup can be reached on 571-272-6897. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LEZAH ROBERTS/Primary Examiner, Art Unit 1612
Read full office action

Prosecution Timeline

Show 34 earlier events
Feb 06, 2025
Response after Non-Final Action
Feb 06, 2025
Response after Non-Final Action
Nov 18, 2025
Response after Non-Final Action
Jan 16, 2026
Request for Continued Examination
Jan 20, 2026
Response after Non-Final Action
Feb 11, 2026
Non-Final Rejection mailed — §103
May 07, 2026
Response Filed
Jul 21, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12734116
CATIONIC MATERIAL FOR TOOTH DESENSITIZATION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
2y 1m to grant Granted Sep 15, 2026
Patent 12702631
Oral Care Compositions Comprising Hops Beta Acids And Fluoride Ions
1y 2m to grant Granted Aug 11, 2026
Patent 12697288
COMPOSITION FOR ORAL CAVITY
5y 3m to grant Granted Aug 04, 2026
Patent 12691045
Rheological Solid Composition for Use in Shaving
5y 3m to grant Granted Jul 28, 2026
Patent 12661309
PREPARATION AND EFFICACY OF TOOTH WHITENING TABLET INCLUDING SHMP
5y 0m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

10-11
Expected OA Rounds
48%
Grant Probability
84%
With Interview (+35.4%)
4y 1m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 770 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month